Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Recent Patents on Nanotechnology|April 3, 2023
A Complete Sojourn of Current Trends in Gastro-retentive Drug Delivery System: Recent Advances and Patent SurveyAbhisek Dey, Amrinder Singh, Balak Das Kurmi, et al.
Exploration of Targeted Anti-Tumor Therapy|November 7, 2022
Potential role of resveratrol and its nano-formulation as anti-cancer agentAkshay Kumar, Balak Das Kurmi, Amrinder Singh, et al.
Current Pharmaceutical Design|November 1, 2024
Nano Revolution: Harnessing Nanoparticles to Combat Antibiotic-resistant Bacterial InfectionsAkash Vikal, Rashmi Maurya, Preeti Patel, et al.
Assay and Drug Development Technologies|January 8, 2025
Future Prospects and Regulatory Pathways for Invasome Technologies in Transdermal Drug DeliveryDinesh Kumar, Debayan Sil, Balak Das Kurmi, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 16, 2026
Recent Advances in Intravesical Chemotherapy: Insights into the FDA-Approved Gemcitabine-Releasing TAR-200 System for Bladder Cancer ManagementAbhishek Sharma, Aman Kumar, Preeti Patel, et al.
Recent Advances in Inflammation & Allergy Drug Discovery|July 31, 2025
Apremilast in Psoriasis: Current Landscape and PerspectivesDinesh Kumar, Debayan Sil, Balak Das Kurmi, et al.
Archiv Der Pharmazie|February 8, 2026
Decoding MYC Targeted Inhibition in Cancer: Integrating Medicinal Insights With Computational Design ApproachesSubhankar Pradhan, Shivani Kasana, Balak Das Kurmi, et al.
Immunological Investigations|March 16, 2026
Immunometabolic Dysregulation in Psoriasis: Mechanisms Driving Inflammation and Emerging Therapeutic TargetsAditya Jaswal, Aman Kumar, Preeti Patel, et al.
Recent Patents on Nanotechnology|June 2, 2023
Recent Advancements in Novel Formulations of Anti-psoriatic Agents for Effective Delivery: Clinical Importance and Patent SurveyNikhil Dadwal, Balak Das Kurmi, Dilpreet Singh, et al.
RSC Medicinal Chemistry|May 20, 2026
From scaffold to selectivity-medicinal insights of PRMT1 and PRMT4 inhibitors for epigenetic cancer therapyKanchan Pal, Shivani Kasana, Balak Das Kurmi, et al.
Pageof 11